GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 68 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,880,000 | -9.5% | 52,227 | +3.6% | 0.01% | -14.3% |
| Q2 2020 | $3,183,000 | +48.3% | 50,420 | +20.1% | 0.01% | +16.7% |
| Q1 2020 | $2,146,000 | -56.0% | 41,987 | -31.6% | 0.01% | -40.0% |
| Q4 2019 | $4,878,000 | +63.9% | 61,362 | 0.0% | 0.01% | +42.9% |
| Q3 2019 | $2,977,000 | -7.6% | 61,362 | +0.2% | 0.01% | 0.0% |
| Q2 2019 | $3,221,000 | -0.6% | 61,243 | +0.1% | 0.01% | -12.5% |
| Q1 2019 | $3,240,000 | +28.9% | 61,211 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $2,513,000 | +17.4% | 61,211 | +8.6% | 0.01% | +40.0% |
| Q3 2018 | $2,141,000 | +25.6% | 56,342 | +49.5% | 0.01% | +150.0% |
| Q2 2018 | $1,704,000 | +61.5% | 37,688 | +72.5% | 0.00% | 0.0% |
| Q1 2018 | $1,055,000 | -42.0% | 21,842 | -49.4% | 0.00% | -50.0% |
| Q3 2015 | $1,820,000 | – | 43,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |